Type Public Headquarters Midrand, South Africa | Traded as JSE: AIP Number of employees 2,374 | |
 | ||
Industry Health Care, Pharmaceuticals Area served South Africa and Selected Emerging Markets (southern Africa, Ghana, India) Key people Andy Hall (CEO)
Dorette Neethling (CFO Acting)
Clifford Raphiri (Chairman) Products Pharmaceuticals and Health Care Stock price AIP (JSE) 5,900.00 ZAC +32.00 (+0.55%)2 Mar, 9:05 AM GMT+2 - Disclaimer CEO Kevin Wakeford (3 Apr 2014–) | ||
Adcock ingram announced a five year deal to co promote and distribute products for msd
Adcock Ingram is a South African pharmaceutical company listed on the Johannesburg Stock Exchange. Adcock Ingram manufactures and markets a wide range of healthcare products. The company is a leading supplier to both the private and public sectors of the market. Adcock Ingram has four commercial divisions: Consumer, OTC, Prescription and Critical Care. Its market capitalisation is about R9 billion.
Contents
- Adcock ingram announced a five year deal to co promote and distribute products for msd
- Adcock ingram s owner driver scheme in south africa
- History
- References
Adcock Ingram is a level 4 B-BBEE contributor.
Adcock ingram s owner driver scheme in south africa
History
Adcock Ingram first started out as a pharmacy in Krugersdorp trading under the name EJ Adcock Pharmacy in 1891. In the early 1900s, Hyme Tannenbaum was apprenticed to then owner, Jack Blair. Hyme's brothers Jack, Len and Archie soon followed him into the pharmacy, which they eventually bought. Beginning with this one small pharmacy, the Tannenbaum brothers built a cross-country chain of retail pharmacies, a pharmaceutical and toiletry manufacturing giant and a highly respected South African success story. Adcock Ingram was first listed on the Johannesburg Stock Exchange in 1950. The company was sold to Tiger Brands in 1999 for R3.4 billion. In August 2008 Adcock Ingram relisted on the JSE with 172.6 million ordinary issued shares at a price of R33.50 each.